BiotechTube
Antibody Solutions

Antibody Solutions

Sunnyvale, United States· Est.
antibody.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10.5M

Overview

Antibody Solutions is a long-established, privately-held contract research organization providing comprehensive antibody discovery and development services to the biopharmaceutical industry. The company leverages over 30 years of expertise and a diverse technology platform, including its proprietary Cellestive Discovery Platform, to generate therapeutic and diagnostic antibody candidates for its clients. Its business model is purely service-based, retaining no IP rights, which has fostered trust with over 700 biopharma companies, including all top 10 global research pharmas. The company is in a mature, revenue-generating stage, supported by a high client retention rate of 96%.

Antibodies

Technology Platform

Cellestive Discovery Platform: an integrated suite of antibody discovery methods including B-cell sourcing (Plasma, Activated, Memory), transgenic animal platforms, alternative antibody modalities (fragments, bispecifics), and supporting services in antigen development, sequencing, and molecular modeling.

Funding History

2
Total raised:$10.5M
Series A$8.5M
Seed$2M

Opportunities

The growing global antibody therapeutics market and the biopharma industry's trend toward outsourcing R&D create sustained demand for expert discovery services.
Expansion into supporting new modalities like ADCs and bispecifics, as well as the stable market for critical assay reagents, presents multiple growth avenues.

Risk Factors

Revenue is tied to biopharma R&D spending, which is susceptible to economic downturns.
The company faces intense competition from other CROs and must continuously invest in new technologies to avoid obsolescence.
Operational success is critical, as failure to deliver on projects could damage its strong reputation and client retention.

Competitive Landscape

Antibody Solutions competes in the crowded contract research organization (CRO) space for antibody discovery, facing competition from large, full-service CROs (e.g., Charles River, Labcorp), specialized antibody-focused firms (e.g., AbCellera, BioAtla), and large service providers from Asia (e.g., GenScript). Its key differentiators are its long-standing reputation, full-service 'Cellestive' platform, and IP-friendly fee-for-service model.

More companies in Biologics / Biosimilars →More companies in United States →